• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
California Health Advocates

California Health Advocates

  • Contact
  • Home
  • About Us
    • Contact
    • Our Team
    • Mission
    • Education Services
    • About HICAP
    • Press
    • Testimonials
  • MEDICARE COUNSELING
  • Fact Sheets
  • Topics
    • The Basics
    • Prescription Drugs
    • Low-Income Help
    • Medigap
    • Medicare Advantage
    • Other Health Insurance
    • Appeals
    • Billing & Claims
    • Disabilities
    • Long-Term Care
    • Tribal Nations & Medicare
    • Health Care Reform
    • Advocacy & Policy
    • Glossary
  • Fraud & Abuse
  • Medicare Complaints
  • Blog
  • Donate

Prescription Drugs - Blog

California Health Advocates > Prescription Drugs - Blog

Medicare Expands Part B Immunosuppressive Drug Benefit for People with Kidney Transplants

Posted by Karen Joy Fletcher on January 3, 2023

kidney health, immunosuppressive drugs

In the past, people on Medicare due to kidney failure, or end stage renal disease (ESRD) were eligible for 36 months of Medicare coverage after a successful kidney transplant. This coverage was crucial in large part for the payment of the hugely expensive immunosuppressive drugs necessary to prevent rejection of the transplanted kidney and keep it functioning well. Yet, unless … [Read more...] about Medicare Expands Part B Immunosuppressive Drug Benefit for People with Kidney Transplants

Filed Under: Medicare Basics, Low-Income help, Prescription Drugs - Blog, Professionals

Understanding New Rules Regarding Insulin Costs & Rights to Switch Plans

Posted by Karen Joy Fletcher on December 14, 2022

insulin

One of the many good provisions in the Inflation Reduction Act of 2022 (IRA) is the cap on out-of-pocket costs for all insulin drugs. The IRA limits out-of-pocket costs to no more than $35 per 30-day insulin prescription under all Medicare drug prescription plans. Plans also cannot charge a deductible for insulin. This means that a 60-day supply would be no more than $70, … [Read more...] about Understanding New Rules Regarding Insulin Costs & Rights to Switch Plans

Filed Under: Prescription Drugs - Blog, Low-Income Help, Prescription Drugs, Professionals

Learn How the Inflation Reduction Act of 2022 Will Significantly Reduce Drug Costs

Posted by Karen Joy Fletcher on September 1, 2022

Inflation Reduction Act - prescription drugs on a table from a bottle

Last month Congress passed the historic Inflation Reduction Act of 2022. Some of the many significant pieces of this legislation are a plethora of Medicare prescription drug reforms and protections to shield people from high drug costs. This is great news, and the changes coming will help lower prescription drug costs for all people on Medicare, and especially older adults with … [Read more...] about Learn How the Inflation Reduction Act of 2022 Will Significantly Reduce Drug Costs

Filed Under: Prescription Drugs - Blog, Low-Income help, Prescription Drugs

Draft Bill Provides Needed Prescription Drug Pricing Reform

Posted by Karen Joy Fletcher on July 19, 2022

prescription drug, variety of colorful pills

In early July, the Senate Finance Committee drafted legislation to help address the burdensome, high prescription drug prices affecting Medicare beneficiaries, and aims to have it passed through the upcoming reconciliation process. This legislation would allow Medicare to negotiate drug prices, cap beneficiary out-of-pocket costs to $2,000 annually starting in 2025, and … [Read more...] about Draft Bill Provides Needed Prescription Drug Pricing Reform

Filed Under: Prescription Drugs, Prescription Drugs - Blog

CMS’ Finalized Rules Will Lower Drug Costs & Increase Consumer Protections

Posted by Karen Joy Fletcher on May 12, 2022

drug costs - wood scales with stack of pills

In late April, the Centers for Medicare and Medicaid Services (CMS) issued finalized rules to both strengthen consumer protections in Medicare Advantage and Part D drug plans, and reduce out-of-pocket drug costs for beneficiaries. As summarized in CMS' recent fact sheet, this final rule revises the MA and Part D regulations related to marketing and communications; the … [Read more...] about CMS’ Finalized Rules Will Lower Drug Costs & Increase Consumer Protections

Filed Under: Medicare Advantage, Prescription Drugs - Blog

Next Page »

Primary Sidebar

Change Text Size

  • 100%  110%  120%  130%  

News & Blog Categories

  • Medicare Advantage
  • Low-Income help
  • Medicare & Disabilities
  • Medicare Basics
  • Prescription Drugs
  • Medicare & Other Health Insurance
  • Medicare Billings, Claims & Appeals
  • Health Care Disparities
  • Fraud & Abuse

—

  • COVID-19
  • Resources
  • Health Care Reform
  • Long-Term Care
  • CHA News

—

  • Advocacy & Policy
  • Letters and Comments to Policymakers
  • Legislative and Congressional Testimony
  • Policy Briefs

Send Us Comment

Do you have comments or concerns about your Medicare coverage? Issues regarding getting your needed prescriptions from your Part D plan, or a Medicare Advantage plan representative's marketing practices? Let us know at comments@cahealthadvocates.org.

We are dedicated to making Medicare's program work well for all beneficiaries. Your feedback from your own or your client's concerns and experiences with Medicare, will guide our Medicare advocacy efforts with key policy and decision-makers in both California and nationally with the Centers for Medicare and Medicaid Services (CMS) and Congress.

Archives

Donate Today

Footer

Sign up for our newsletter

Choose the news you'd like to receive

Important Links

  • About Us
  • Fact Sheets
  • Blog
  • Donate
  • Contact
  • Privacy Notice
  • Cookie Policy
  • Accessibility Statement

Follow Us

Copyright © 2023 · California Health Advocates · Web Design by TWK Web and Print Design · Log in